Advocate Group’s Amgen AMGN Stock Holding History

Advocate Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.12M	Sell	5,028 -170	-3%	-$67.8K	0.33%	77
2026 Q2	$1.88M	Sell	5,198 -280	-5%	-$95.8K	0.28%	78
2026 Q1	$1.93M	Sell	5,478 -19	-0.3%	-$6.77K	0.3%	74
2025 Q4	$1.8M	Sell	5,497 -37	-0.7%	-$11.7K	0.29%	76
2025 Q3	$1.56M	Sell	5,534 -253	-4%	-$73.4K	0.26%	76
2025 Q2	$1.62M	Sell	5,787 -371	-6%	-$105K	0.29%	73
2025 Q1	$1.92M	Sell	6,158 -17	-0.3%	-$5.02K	0.35%	69
2024 Q4	$1.61M	Sell	6,175 -38	-0.6%	-$11.3K	0.3%	72
2024 Q3	$2M	Sell	6,213 -42	-0.7%	-$13.7K	0.36%	70
2024 Q2	$1.95M	Sell	6,255 -268	-4%	-$78.7K	0.39%	69
2024 Q1	$1.85M	Sell	6,523 -240	-4%	-$70.2K	0.37%	71
2023 Q4	$1.95M	Sell	6,763 -797	-11%	-$217K	0.42%	73
2023 Q3	$2.03M	Sell	7,560 -813	-10%	-$203K	0.47%	66
2023 Q2	$1.86M	Sell	8,373 -1,349	-14%	-$313K	0.41%	67
2023 Q1	$2.35M	Sell	9,722 -1,775	-15%	-$436K	0.51%	65
2022 Q4	$3.02M	Sell	11,497 -819	-7%	-$220K	0.65%	58
2022 Q3	$2.78M	Sell	12,316 -480	-4%	-$116K	0.69%	52
2022 Q2	$3.11M	Buy	+12,796	New	+$3.14M	0.72%	51

Other funds holding AMGN

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Smead Capital Management Phoenix, Arizona $4.71B AUM 32.07% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Advocate Group's AMGN Position: Q3 2026 in Review

Advocate Group reduced its Amgen (AMGN) stake by 3.3% in Q3 2026, selling an estimated $67.8K and leaving 5,028 shares worth $2.12M. The position accounts for 0.33% of the portfolio, ranked #77.

Advocate Group first reported a position in AMGN in Q2 2022 and has held it in 18 quarters since. The position peaked at $3.11M in Q2 2022. 1,594 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

Advocate Group held 5,028 shares of Amgen worth $2.12M as of Q3 2026.
Advocate Group sold 170 Amgen shares in Q3 2026, an estimated $67.8K.
Amgen made up 0.33% of Advocate Group's portfolio in Q3 2026, its #77 holding.
Advocate Group first reported a position in Amgen in Q2 2022 and has held it in 18 quarters since.
Advocate Group's Amgen position peaked at $3.11M in Q2 2022.
1,594 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Advocate Group's 13F filing for Q3 2026, filed 19 Oct 2026.